| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |